Lewy body disorders are a family of neurological brain disorders associated with olfactory, motor, and cognitive deficits and are collectively defined as α-synucleinopathies, as they are characterized by hallmark “Lewy bodies” composed of aggregated, fibrillar α-synuclein. It is not certain but often posited that fibrillar α-synuclein seeds the progressive, self-propagating spread of Lewy pathology through neuroanatomical circuitry. Furthermore, the site of disease induction is still debated. In Aim I, we developed a novel protocol for generating reproducible and robust α-synucleinopathy in the limbic temporal lobe following infusions of preformed α-synuclein iv fibrils into the mouse olfactory bulb, which is frequently the first brain region to display Lewy pathology in humans. Our tract-tracer studies revealed that all areas displaying dense Lewy-like pathology were indeed connected to the induction site. The pattern of α-synucleinopathy resembled that of Stage IIb of Beach’s unified staging theory rather than Parkinson’s disease. In Aim 2, we observed that α-synucleinopathy also remained confined to the limbic connectome regardless of gender, age, or incubation period. Lewy pathology that developed in the ventral mesencephalon was confined to the ventral tegmental area, which is also associated with limbic functions. Furthermore, our studies are the first to show that females are more resistant to the development of α-synucleinopathy and neurodegeneration than males, and that fibril infusions hastened mortality in aged mice. In Aim 3, N-acetyl cysteine protected primary neuron cultures against proteotoxicity, including that of α-synuclein fibrils, and the mechanism appeared to be partly dependent on the chaperone activity of heat shock protein 70. These findings were expanded to an in vivo study, in which mice were fed N-acetyl cysteine for 90 days after induction of olfactory α-synucleinopathy. Oral N-acetyl cysteine reduced Lewy-like pathology, but only in the anterior olfactory nucleus, the area of densest α-synucleinopathy in this model. In conclusion, we have developed a robust model of early-stage Lewy body disorders that appears to mimic the higher risk of Lewy body disorders in men and the acceleration of mortality with aging in these conditions.
","abstract_html":"<p>Lewy body disorders are a family of neurological brain disorders associated with olfactory, motor, and cognitive deficits and are collectively defined as α-synucleinopathies, as they are characterized by hallmark “Lewy bodies” composed of aggregated, fibrillar α-synuclein. It is not certain but often posited that fibrillar α-synuclein seeds the progressive, self-propagating spread of Lewy pathology through neuroanatomical circuitry. Furthermore, the site of disease induction is still debated. In Aim I, we developed a novel protocol for generating reproducible and robust α-synucleinopathy in the limbic temporal lobe following infusions of preformed α-synuclein iv fibrils into the mouse olfactory bulb, which is frequently the first brain region to display Lewy pathology in humans. Our tract-tracer studies revealed that all areas displaying dense Lewy-like pathology were indeed connected to the induction site. The pattern of α-synucleinopathy resembled that of Stage IIb of Beach’s unified staging theory rather than Parkinson’s disease. In Aim 2, we observed that α-synucleinopathy also remained confined to the limbic connectome regardless of gender, age, or incubation period. Lewy pathology that developed in the ventral mesencephalon was confined to the ventral tegmental area, which is also associated with limbic functions. Furthermore, our studies are the first to show that females are more resistant to the development of α-synucleinopathy and neurodegeneration than males, and that fibril infusions hastened mortality in aged mice. In Aim 3, N-acetyl cysteine protected primary neuron cultures against proteotoxicity, including that of α-synuclein fibrils, and the mechanism appeared to be partly dependent on the chaperone activity of heat shock protein 70. These findings were expanded to an in vivo study, in which mice were fed N-acetyl cysteine for 90 days after induction of olfactory α-synucleinopathy. Oral N-acetyl cysteine reduced Lewy-like pathology, but only in the anterior olfactory nucleus, the area of densest α-synucleinopathy in this model. In conclusion, we have developed a robust model of early-stage Lewy body disorders that appears to mimic the higher risk of Lewy body disorders in men and the acceleration of mortality with aging in these conditions.</p>","abstract_has_math":false,"creators":["MASON, DANIEL"],"institution":null,"degree_name":"PhD","degree_level":"One-year Embargo","degree_discipline":"Pharmacology","degree_department":null,"school":null,"contributors":["Dr. Rehana Leak","Dr. David Johnson","Dr. Jane Cavanaugh","Dr. Paula Witt-Enderby","Dr. John Stolz"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-12-21T08:00:00Z","date_published":"2018-12-21T08:00:00Z","updated_at":"2026-07-24T02:10:50Z","subjects":["Parkinson's","Lewy","synuclein","olfactory","fibril","dementia","Other Pharmacy and Pharmaceutical Sciences"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/1726","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Rehana Leak","Dr. David Johnson","Dr. Jane Cavanaugh","Dr. Paula Witt-Enderby","Dr. John Stolz"]},{"key":"dc:creator","label":"Author","values":["MASON, DANIEL"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-12-21T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmacology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["One-year Embargo"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Parkinson's","Lewy","synuclein","olfactory","fibril","dementia","Other Pharmacy and Pharmaceutical Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/1726"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Lewy body disorders are a family of neurological brain disorders associated with olfactory, motor, and cognitive deficits and are collectively defined as α-synucleinopathies, as they are characterized by hallmark “Lewy bodies” composed of aggregated, fibrillar α-synuclein. It is not certain but often posited that fibrillar α-synuclein seeds the progressive, self-propagating spread of Lewy pathology through neuroanatomical circuitry. Furthermore, the site of disease induction is still debated. In Aim I, we developed a novel protocol for generating reproducible and robust α-synucleinopathy in the limbic temporal lobe following infusions of preformed α-synuclein iv fibrils into the mouse olfactory bulb, which is frequently the first brain region to display Lewy pathology in humans. Our tract-tracer studies revealed that all areas displaying dense Lewy-like pathology were indeed connected to the induction site. The pattern of α-synucleinopathy resembled that of Stage IIb of Beach’s unified staging theory rather than Parkinson’s disease. In Aim 2, we observed that α-synucleinopathy also remained confined to the limbic connectome regardless of gender, age, or incubation period. Lewy pathology that developed in the ventral mesencephalon was confined to the ventral tegmental area, which is also associated with limbic functions. Furthermore, our studies are the first to show that females are more resistant to the development of α-synucleinopathy and neurodegeneration than males, and that fibril infusions hastened mortality in aged mice. In Aim 3, N-acetyl cysteine protected primary neuron cultures against proteotoxicity, including that of α-synuclein fibrils, and the mechanism appeared to be partly dependent on the chaperone activity of heat shock protein 70. These findings were expanded to an in vivo study, in which mice were fed N-acetyl cysteine for 90 days after induction of olfactory α-synucleinopathy. Oral N-acetyl cysteine reduced Lewy-like pathology, but only in the anterior olfactory nucleus, the area of densest α-synucleinopathy in this model. In conclusion, we have developed a robust model of early-stage Lewy body disorders that appears to mimic the higher risk of Lewy body disorders in men and the acceleration of mortality with aging in these conditions.
"]},{"key":"dc:title","label":"Title","values":["The Influence of Age, Gender, and Thiol Repletion in an In Vivo Model of Lewy Body Disorders"]}]}],"canonical_facts":{"dc:contributor":["Dr. Rehana Leak","Dr. David Johnson","Dr. Jane Cavanaugh","Dr. Paula Witt-Enderby","Dr. John Stolz"],"dc:creator":["MASON, DANIEL"],"dc:date.available":["2019-12-21T08:00:00Z"],"dc:description.abstract":["Lewy body disorders are a family of neurological brain disorders associated with olfactory, motor, and cognitive deficits and are collectively defined as α-synucleinopathies, as they are characterized by hallmark “Lewy bodies” composed of aggregated, fibrillar α-synuclein. It is not certain but often posited that fibrillar α-synuclein seeds the progressive, self-propagating spread of Lewy pathology through neuroanatomical circuitry. Furthermore, the site of disease induction is still debated. In Aim I, we developed a novel protocol for generating reproducible and robust α-synucleinopathy in the limbic temporal lobe following infusions of preformed α-synuclein iv fibrils into the mouse olfactory bulb, which is frequently the first brain region to display Lewy pathology in humans. Our tract-tracer studies revealed that all areas displaying dense Lewy-like pathology were indeed connected to the induction site. The pattern of α-synucleinopathy resembled that of Stage IIb of Beach’s unified staging theory rather than Parkinson’s disease. In Aim 2, we observed that α-synucleinopathy also remained confined to the limbic connectome regardless of gender, age, or incubation period. Lewy pathology that developed in the ventral mesencephalon was confined to the ventral tegmental area, which is also associated with limbic functions. Furthermore, our studies are the first to show that females are more resistant to the development of α-synucleinopathy and neurodegeneration than males, and that fibril infusions hastened mortality in aged mice. In Aim 3, N-acetyl cysteine protected primary neuron cultures against proteotoxicity, including that of α-synuclein fibrils, and the mechanism appeared to be partly dependent on the chaperone activity of heat shock protein 70. These findings were expanded to an in vivo study, in which mice were fed N-acetyl cysteine for 90 days after induction of olfactory α-synucleinopathy. Oral N-acetyl cysteine reduced Lewy-like pathology, but only in the anterior olfactory nucleus, the area of densest α-synucleinopathy in this model. In conclusion, we have developed a robust model of early-stage Lewy body disorders that appears to mimic the higher risk of Lewy body disorders in men and the acceleration of mortality with aging in these conditions.
"],"dc:identifier":["https://dsc.duq.edu/etd/1726"],"dc:language":["English"],"dc:subject":["Parkinson's","Lewy","synuclein","olfactory","fibril","dementia","Other Pharmacy and Pharmaceutical Sciences"],"dc:title":["The Influence of Age, Gender, and Thiol Repletion in an In Vivo Model of Lewy Body Disorders"],"thesis:degree_discipline":["Pharmacology"],"thesis:degree_level":["One-year Embargo"],"thesis:degree_name":["PhD"]},"updated_at":"2026-07-24T02:10:50Z"}